πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9314448

Method of inhibiting ABCG2 and other treatment methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9314532

Drug delivery vehicle

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9316646

Anti-human ROR1 antibodies

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9309237

HIV inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9308163

Methods of treating and preventing diseases and disorders of the central nervous system

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9303044

7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of throm

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9296790

Methods and compositions for protein delivery

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9290512

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9283233

Method for on-demand contraception

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278089

Method of treating HCV infection with a small molecule CHK2 inhibitor

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9277748

Agonist/antagonist compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278090

Methods of preventing the development of mucositis and related disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9273121

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9273124

Monoclonal antibodies that react with the capsule of Bacillus anthracis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9273136

Fully human anti-human NKG2D monoclonal antibodies

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9272023

Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9266960

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9266928

Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved ant

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9259463

Chlamydia vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9243036

Anti-microbial activity of synthetic peptides

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238069

Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in c

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238684

SPANX-B polypeptides and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238799

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238800

Avian adenoassociated virus and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted